Michael Taylor named director of the Pediatric Neuro-Oncology Research Program at Texas Children’s and Baylor

Pan-cancer proteogenomics reveals potential drug targets

Researchers at Baylor College of Medicine and collaborating institutions have uncovered new potential therapeutic targets for cancer and new insights into existing cancer drug targets.

June 28, 2024

Vol.50 No.26

Clinical Roundup

PKMYT1 is a potential target for treatment-resistant ER+ breast cancers

Up to 80% of breast cancer deaths occur in patients with tumors that express estrogen receptor-alpha, according to a study published in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research.

May 31, 2024

Vol.50 No.22

In Brief

Shanda Blackmon named director of Baylor’s Lung Institute

Shanda H. Blackmon was named director of the Lung Institute at Baylor Medicine.

April 26, 2024

Vol.50 No.17

In Brief

UF Health Proton Therapy Institute adds interactive video wall for pediatric patients

The UF Health Proton Therapy Institute enhanced its playroom, a respite for its pediatric patients, significantly with innovative technology that promotes therapeutic engagement, with an 86” interactive gaming wall that features educational and sensory software.

March 29, 2024

Vol.50 No.13

Clinical Roundup

USC researchers find genetic variant contributing to disparities in childhood leukemia risk

Researchers from the University of Southern California found a genetic variant contributing to disparities in childhood leukemia risk. The variant, located on the IKZF1 gene, helps explain why Hispanic/Latino children face a higher risk of acute lymphoblastic leukemia and offers insights about what causes the disease.

March 29, 2024

Vol.50 No.13

In Brief

Fox Chase’s Joshua Cohn named consultant to Shriners Children’s Philadelphia

Joshua Cohn, associate professor in the Department of Urology at Fox Chase Cancer Center and a member of the Fox Chase – Temple Urologic Institute, was named a consultant at Shriners Children’s Philadelphia.

February 16, 2024

Vol.50 No.07

Michael Taylor named director of the Pediatric Neuro-Oncology Research Program at Texas Children’s and Baylor

YOU MAY BE INTERESTED IN

Pan-cancer proteogenomics reveals potential drug targets

PKMYT1 is a potential target for treatment-resistant ER+ breast cancers

Shanda Blackmon named director of Baylor’s Lung Institute

UF Health Proton Therapy Institute adds interactive video wall for pediatric patients

USC researchers find genetic variant contributing to disparities in childhood leukemia risk

Fox Chase’s Joshua Cohn named consultant to Shriners Children’s Philadelphia

Renew today!

Subscriber content

Login